Repeated consumption of grapefruit juice considerably increases plasma concentrations of cisapride

Clinical Pharmacology and Therapeutics

Volumn 66, Issue 5, 1999, Pages 448-453

  Kivistö, Kari T ^b   Lilja, Jari J ^b   Backman, Janne T ^b   Neuvonen, Pertti J ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIETARY INTAKE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; FOOD DRUG INTERACTION; FRUIT; FRUIT JUICE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032749066     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(99)70007-X     Document Type: Article

References (26)

1. 1. McCallum RW. Cisapride: a new class of prokinetic agent. Am J Gastroenterol 1991;86:135-49.
2. 2. Bran S, Murray WA, Hirsch IB, Palmer JP. Long QT syndrome during high-dose cisapride. Arch Intern Med 1995;155:765-8.
3. 3. Lewin MB, Bryant RM, Fenrich AL, Grifka RG. Cisapride induced long QT interval. J Pediatr 1996;128: 279-81.
4. 4. Thomas AR, Chan LN, Bauman JL, Olopade CO. Prolongation of the QT interval related to cisapride-diltiazem interaction. Pharmacotherapy 1998;18:381-5.
5. 5. Sekkarie MA. Torsades de pointes in two chronic renal failure patients treated with cisapride and clarithromycin. Am J Kidney Dis 1997;30:437-9.
6. 6. Wysowski DK, Bacsanyi J. Cisapride and fatal arrhythmia. N Engl J Med 1996;335:290-1.
7. 7. Bailey DG, Arnold JMO, Munoz C, Spence JD. Grapefruit juice-felodipine interaction: mechanism, predictability, and effect of naringin. Clin Pharmacol Ther 1993;53:637-42.
8. 8. Yee GC, Stanley DL, Pessa LJ, Costa TD, Beltz SD, Ruiz J, et al. Effect of grapefruit juice on blood cyclosporin concentration. Lancet 1995;345:955-6.
9. 9. Ducharme MP, Warbasse LH, Edwards DJ. Disposition of intravenous and oral cyclosporin after administration with grapefruit juice. Clin Pharmacol Ther 1995;57: 485-91.
10. 10. Rau SE, Bend JR, Arnold JMO, Tran LT, Spence JD, Bailey DG. Grapefruit juice-terfenadine single-dose interaction: magnitude, mechanism, and relevance. Clin Pharmacol Ther 1997;61:401-9.
11. 11. Lilja JJ, Kivistö KT, Backman JT, Lamberg TS, Neuvonen PJ. Grapefruit juice substantially increases plasma concentrations of buspirone. Clin Pharmacol Ther 1998;64:655-60.
12. 12. Lilja JJ, Kivistö KT, Neuvonen PJ. Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin Pharmacol Ther 1998;64:477-83.
13. 13. Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, et al. Grapefruit juice increases felodipine oral bioavailability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 1997;99:2545-53.
14. 14. Desta Z, Thacker D, Soukhova N, Shin JG, Flockhart DA. Identification and characterization of human cytochrome P450 (CYP) isoforms interacting with cisapride [abstract]. Clin Pharmacol Ther 1999;65:126.
15. 15. Gotschall RR, Marcucci K, Leeder JS, Kearns GL. Cisapride biotransformation: not all CYP3As are created equal [abstract]. Clin Pharmacol Ther 1999;65:127.
16. 16. Woestenborghs R, Lorreyne W, van Rompaey F, Heykants J. Determination of cisapride in plasma and animal tissues by high-performance liquid chromatography. J Chromatogr 1988;424:195-200.
17. 17. Preechagoon Y, Charles BG. Analysis of cisapride in neonatal plasma and animal tissue using high-performance liquid chromatography with a base-stable column and fluorescence detection. J Chromatogr B Biomed Sci Appl 1995;670:139-43.
18. 18. Puisieux FL, Adamantidis MM, Dumotier BM, Dupuis BA. Cisapride-induced prolongation of cardiac action potential and early afterdepolarizations in rabbit Purkinje fibres. Br J Pharmacol 1996;117:1377-9.
19. 19. Drolet B, Khalifa M, Daleau P, Hamelin BA, Turgeon J. Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval. Circulation 1998;97:204-10.
20. 20. van Haarst AD, van 't Klooster GAE, van Gerven JMA, Schoemaker RC, van Ocne JC, Burggraaf J, et al. The influence of cisapride and clarithromycin on QT intervals in healthy volunteers. Clin Pharmacol Ther 1998;64:542-6.
21. 21. Clifford CP, Adams DA, Murray S, Taylor GW, Wilkins MR, Boobis AR, et al. The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice. Eur J Clin Pharmacol 1997;52:311-5.
22. 22. Benton RE, Honig PK, Zamani K, Cantilena LR, Woosley RL. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram. Clin Pharmacol Ther 1996;59:383-8.
23. 23. Honig PK, Wortham DC, Lazarev A, Cantilena LR. Grapefruit juice alters the systemic bioavailability of terfenadine and cardiac repolarization of terfenadine in poor metabolizers of terfenadine. J Clin Pharmacol 1996;36:345-51.
24. 24. Ameer B, Weintraub RA. Drug interactions with grapefruit juice. Clin Pharmacokinet 1997;33:103-21.
25. 25. Bailey DG, Malcolm J, Arnold O, Spence JD. Grapefruit juice-drug interactions. Br J Clin Pharmacol 1998;46: 101-10.
26. 26. Gross AS, Goh YD, Addison RS, Shenfield GM. Influence of grapefruit juice on cisapride pharmacokinetics. Clin Pharmacol Ther 1999;65:395-401.